Cargando…
A brief review on resistance to P2Y(12) receptor antagonism in coronary artery disease
BACKGROUND: Platelet inhibition is important for patients with coronary artery disease. When dual antiplatelet therapy (DAPT) is required, a P2Y(12)-antagonist is usually recommended in addition to standard aspirin therapy. The most used P2Y(12)-antagonists are clopidogrel, prasugrel and ticagrelor....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558673/ https://www.ncbi.nlm.nih.gov/pubmed/31198410 http://dx.doi.org/10.1186/s12959-019-0197-5 |